ClinicalTrials.Veeva

Menu

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

Baylor College of Medicine logo

Baylor College of Medicine

Status

Enrolling

Conditions

Functional Bowel Disorder
Irritable Bowel Syndrome
Functional Gastrointestinal Disorders
Functional Abdominal Pain Disorders
Functional Abdominal Pain
Functional Abdominal Pain Syndrome

Treatments

Other: Cognitive Behavioral Therapy
Other: Low FODMAP Diet

Study type

Interventional

Funder types

Other

Identifiers

NCT03823742
H-43391

Details and patient eligibility

About

The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

Full description

AIM 1: We will categorize children ages 7-12 yrs. of age with FGIDs (n=250) as to whether they have/do not have one or more of the following abnormal physiologic changes: a) Autonomic Nervous System imbalance as indicated by low heart rate variability; and/or (b) Abnormalities in gut physiology: Impaired gut barrier function (increased permeability); and/or increased abundance of species of Gammaproteobacteria and/or Clostridia; and/or Gut neuroimmune dysfunction (increased fecal chromogranin A and secretogranin 2 concentrations).

AIM 2: Children will be randomized to the two treatments most commonly used in clinical practice: CBT or a low FODMAP diet for a 3-week treatment period. We will compare the response to the treatments in those with/without abnormal physiologic biomarkers at 3 weeks, 3 months, and 6 months.

Enrollment

250 estimated patients

Sex

All

Ages

7 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A child 7-12 years of age with a FGID will be recruited if the medical evaluation reveals no organic reason for the abdominal pain and the child has abdominal pain that meets the definition of a FGID (i.e., IBS, functional abdominal pain) according to the pediatric Rome III criteria (Rome IV will be substituted when validated). Parents and children must speak and understand English because of the psychological assessment and CBT requirements.

Exclusion criteria

  • Children who have: had past bowel surgery; documented GI disorders (e.g., Crohn's disease); a serious chronic medical condition (e.g., diabetes); weight and/or height < 2 SD for age; chronic conditions with GI symptoms (e.g., cystic fibrosis); autism spectrum disorder, significant developmental delay, psychosis, or a history of bipolar disorder; been treated with antibiotics/probiotics within 2 mo. (because of effects on gut microbiome analysis), and children who for some reason could not be randomized to the low FODMAP diet.Vegetarian; children who are currently on the FODMAP Diet or receiving CBT Children who speak only Spanish are not eligible because the Rome questionnaire and psychological testing are not available in Spanish. Despite this, a large proportion of the children enrolled will be Hispanic.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

250 participants in 2 patient groups

Cognitive Behavioral Therapy
Experimental group
Description:
Cognitive Behavioral Therapy
Treatment:
Other: Cognitive Behavioral Therapy
Low FODMAP diet
Experimental group
Description:
Low FODMAP diet
Treatment:
Other: Low FODMAP Diet

Trial contacts and locations

2

Loading...

Central trial contact

Robert J. Shulman, MD; Cynthia A. Boutte, BSN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems